30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Alexander Fitzpatrick

Track

Insider profile

Currently holds a position at Evofem Biosciences Inc

Performance

Overall performance
3.3
Performance over holding periods
3.3
30 days 90 days 120 days
Average return -11% 8.2% 15.1%
Success rate 1% 68% 82%
Transactions
7 86% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
General Counsel, Secretary Evofem Biosciences Inc Jan. 17, 2018 -
Alexander Fitzpatrick's trades of ARS Pharmaceuticals Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-12 2026-06-12
PlS Planned sale
47,633 -21.7%
241.13
US$588,260 		47,633 -21.7% 241.13 US$588,260
2026-06-12 2026-06-12
PrS Proposed sale
95,354
196.51
US$815,770 		95,354 196.51 US$815,770
2025-05-22 2025-05-20
S Sale
65,041 +39.9%
381.03
US$1,890,507 		65,041 +39.9% 381.03 US$1,890,507
2025-05-20 2025-05-20
PrS Proposed sale
102,969
14.02
US$1,443,894 		102,969 14.02 US$1,443,894
2023-10-02 2023-09-29
B Purchase
46,258 +107.7%
3.78
US$174,994 		46,258 +107.7% 3.78 US$174,994
2023-10-02 2023-09-28
PP Planned purchase
40,000 +1347.3%
3.62
US$144,960 		40,000 +1347.3% 3.62 US$144,960
2021-12-20 2021-12-20
B Purchase
25,000 +8.0%
0.39
US$9,725 		25,000 +8.0% 0.39 US$9,725
2021-06-10 2021-06-10
B Purchase
10,000 +3.3%
1.03
US$10,250 		10,000 +3.3% 1.03 US$10,250
2020-11-18 2020-11-17
B Purchase
9,090 +6.8%
2.20
US$19,998 		9,090 +6.8% 2.20 US$19,998
2018-08-21 2018-08-21
B Purchase
500 +0.7%
2.27
US$1,135 		500 +0.7% 2.27 US$1,135
2018-08-21 2018-08-20
B Purchase
4,500 +6.4%
2.20
US$9,900 		4,500 +6.4% 2.20 US$9,900